Drug intelligence / Profile preview

irvingia gabonensis seed extract

Development stage
Phase 2
Lead developer
Gateway Health Alliances
Modality
Small Molecules
Administration
Oral
01

Overview

IGOB131 is a patented and standardized seed extract derived from the West African plant *Irvingia gabonensis*, commonly known as African mango. It is primarily used as a dietary supplement for weight management and metabolic wellness. Clinical studies have shown that IGOB131 can significantly reduce body weight, waist circumference, and body fat in overweight or obese individuals. The mechanism of action involves modulation of key metabolic pathways related to adipogenesis—specifically impacting PPAR gamma activity, increasing adiponectin levels (which enhances energy balance and reduces fat cell size), decreasing leptin (regulating appetite and satiety), lowering C-reactive protein (a marker of inflammation), improving cholesterol profiles (total cholesterol and LDL cholesterol), reducing blood glucose levels, and inhibiting the enzyme glycerol-3-phosphate dehydrogenase involved in fat storage[2][3][4][7]. The ingredient is generally well-tolerated with mild side effects such as flatulence or headache reported at rates similar to placebo[1][2]. It has been granted U.S. FDA GRAS status.

Brand names
WellTrim iGIGOB131IGOB-131IGOB 131
Other names
African mango extractirvingia gabonensis seed extractIGOB131IGOB-131IGOB 131
02

Targets

AdipoR (Adiponectin receptor)LEPR (Leptin receptor)GPD2 (Glycerol-3-phosphate dehydrogenase 2)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on irvingia gabonensis seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on irvingia gabonensis seed extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call